BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7128695)

  • 1. Presynaptic muscarinic receptors increase striatal dopamine release evoked by "quashi-physiological" depolarization.
    Raiteri M; Marchi M; Maura G
    Eur J Pharmacol; 1982 Sep; 83(1-2):127-9. PubMed ID: 7128695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of muscarinic receptors on striatal synaptosomes increases the release of endogenous dopamine.
    Bonanno G; Marchi M; Raiteri M
    Neuropharmacology; 1985 Mar; 24(3):261-4. PubMed ID: 3990922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Halothane and isoflurane differentially affect the regulation of dopamine and gamma-aminobutyric acid release mediated by presynaptic acetylcholine receptors in the rat striatum.
    Salord F; Keita H; Lecharny JB; Henzel D; Desmonts JM; Mantz J
    Anesthesiology; 1997 Mar; 86(3):632-41. PubMed ID: 9066330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is acetylcholine release from striatal nerve endings regulated by muscarinic autoreceptors?
    Marchi M; Paudice P; Caviglia A; Raiteri M
    Eur J Pharmacol; 1983 Jul; 91(1):63-8. PubMed ID: 6617739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the muscarinic receptor that mediates potentiation of dopamine release negatively coupled to the cyclic GMP system?
    Marchi M; Paudice P; Gemignani A; Raiteri M
    J Neurosci Res; 1987; 17(2):142-5. PubMed ID: 2438426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoregulation of acetylcholine release in isolated hippocampal nerve endings.
    Marchi M; Paudice P; Raiteri M
    Eur J Pharmacol; 1981 Jul; 73(1):75-9. PubMed ID: 7318890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes.
    Martire M; D'Amico M; Panza E; Miceli F; Viggiano D; Lavergata F; Iannotti FA; Barrese V; Preziosi P; Annunziato L; Taglialatela M
    J Neurochem; 2007 Jul; 102(1):179-93. PubMed ID: 17437547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of muscarinic autoreceptors and heteroreceptors in the rat brain: effects of a novel M1 agonist, AF102B.
    Ono S; Saito Y; Ohgane N; Kawanishi G; Mizobe F
    Eur J Pharmacol; 1988 Oct; 155(1-2):77-84. PubMed ID: 3243333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain.
    Raiteri M; Leardi R; Marchi M
    J Pharmacol Exp Ther; 1984 Jan; 228(1):209-14. PubMed ID: 6141277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related decrements in the muscarinic enhancement of K+-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence.
    Joseph JA; Dalton TK; Hunt WA
    Brain Res; 1988 Jun; 454(1-2):140-8. PubMed ID: 2900662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic receptors mediating inhibition of gamma-aminobutyric acid release in rat corpus striatum and their pharmacological characterization.
    Raiteri M; Marchi M; Paudice P; Pittaluga A
    J Pharmacol Exp Ther; 1990 Aug; 254(2):496-501. PubMed ID: 2384883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic receptors mediate direct inhibition of GABA release from rat striatal nerve terminals.
    Marchi M; Sanguineti P; Raiteri M
    Neurosci Lett; 1990 Aug; 116(3):347-51. PubMed ID: 2243614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in muscarinic control of striatal dopamine autoreceptors in senescence: a deficit at the ligand-muscarinic receptor interface?
    Joseph JA; Dalton TK; Roth GS; Hunt WA
    Brain Res; 1988 Jun; 454(1-2):149-55. PubMed ID: 3136856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB; Reuben M
    Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of dopamine from striatal synaptosomes.
    Raiteri M; Cerrito F; Cervoni AM; Del Carmine R; Ribera MT; Levi G
    Ann Ist Super Sanita; 1978; 14(1):97-110. PubMed ID: 227308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic modulation of [3H]dopamine release from dendrosomes of rat substantia nigra.
    Marchi M; Augliera A; Codignola A; Lunardi G; Fedele E; Fontana G; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):275-80. PubMed ID: 1961254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic modulation of the release of dopamine from striatal synaptosomes: differences in the effects of high K+ stimulation, methamphetamine and nicotinic drugs.
    Takano Y; Sakurai Y; Kohjimoto Y; Honda K; Kamiya HO
    Brain Res; 1983 Nov; 279(1-2):330-4. PubMed ID: 6640350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors?
    Raiteri M; Bonanno G; Marchi M; Maura G
    J Pharmacol Exp Ther; 1984 Dec; 231(3):671-7. PubMed ID: 6150107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic receptor concentrations and dopamine release in aged rat striata.
    Yamagami K; Joseph JA; Roth GS
    Neurobiol Aging; 1992; 13(1):51-6. PubMed ID: 1542381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomes.
    Marchi M; Bocchieri P; Garbarino L; Raiteri M
    Neurosci Lett; 1989 Jan; 96(2):229-34. PubMed ID: 2564654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.